Integrated Drug Discovery
Integrated Drug Discovery Services
Pharmaron’s integrated drug discovery services team leads projects from hit identification to candidate selection. We combine world-class scientific and project leadership with global resources and expertise to offer integrated end-to-end support for discovery and development of new therapeutics.
Approach
The collective expertise of our seasoned drug-hunting team, each member with multi-year industry experience and a proven track record, provides strategy, decision-making, and project coordination to transform ideas into high-quality drug candidates.
Expertise
Our integrated drug discovery team has operated for many years across therapeutic areas, target types, and modalities, successfully advancing projects from hit-finding through preclinical candidate selection into the clinic.
Drug Discovery Services with a Flexible Business Model
Whether you need co-piloting, independent delivery, FTE, risk-sharing, or milestone-based services, Pharmaron’s integrated drug discovery CRO team has a solution for you.
Capabilities
Why work with Pharmaron’s drug discovery team?
- Leverage the expertise of an experienced, multi-disciplinary scientific leadership team working in close collaboration with your team
- Benefit from nimble and flexible resource allocation, utilizing Pharmaron’s comprehensive capabilities, instrumentation, and human resources across the UK, US, and China
- Tap into scientific expertise across all relevant research fields and utilize state-of-the-art technology to facilitate efficient Design-Make-Test-Analyze cycles
- Eliminate the coordination between different drug discovery service providers and transform Pharmaron’s industry leading turnaround times into accelerated drug discovery
Therapeutic Expertise
- Cancer
- Metabolic diseases
- Cardiovascular diseases
- Inflammation/pain
- Immunologic diseases
- Neurologic diseases
- Rare diseases
Drug Target Expertise
- Enzymes
- GPCRs
- Transporters
- Chaperones
- Nuclear receptors
- Transcription factors
- Ion channels
- Phenotypic
Beyond preclinical candidate selection: From IND filing to clinical research
At Pharmaron, integrated drug discovery does not stop with selecting a preclinical candidate. Pharmaron is a leader in IND-enabling services and clinical development of new drug candidates. Through collaboration with our regulatory affairs department, our teams generate robust and coherent datasets from the outset, and potential regulatory hurdles are anticipated and addressed proactively. The broad portfolio of Pharmaron allows us to address every part of the IND filing process in-house, including pharmacology, toxicology, manufacturing, and clinical plans. Pharmaron’s integrated approach helps navigate the complexities of the IND enabling phase, setting a solid foundation for successful clinical development.